The Medical Letter on Drugs and Therapeutics
Correction: Pitavastatin (Livalo) - The Seventh Statin
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

In issue 1343, the usual decrease in LDL-cholesterol with pitavastatin (Livalo) in the table on page 58 should have been 35-40% with 2 mg and 40-45% with 4 mg. Also, in the paragraph on Dosage and Administration, the definition of moderately decreased renal function should have been 30-<60 ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Correction: Pitavastatin (Livalo) - The Seventh Statin
Article code: 1344d
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian